"i think that’s one of the reasons the SP is going South, Investors not eager to have their $$$ sitting Idle doing nothing."
I'm not sure about that. Maybe some but most are more forward looking. There are many stocks including huge stocks like Google, that investors bought many, many years before they became cash flow positive and were rewarded hugely for their patience. In oz, you see it with resource stocks that build their market cap as they tick off milestones even years before getting to construction stage. A4N reached a billion market cap around two years before even getting funded for construction which itself will take another two years. I bought very early stage at 16c and sold my last ones around 70c, at least 4 years before they will eventually begun production (not there yet).
You also see it with health care. Some reach market caps in excess of a billion before reaching market sales and some even before completing trials and getting FDA approval. We saw Opthea reach a market cap of $1.5bill before pulling back recently and they just failed their phase three trial!
Why can't LTP climb back above a $100mill mc when it has a clear path to pre-FDA sales in the US in just 12 months and is ramping up off a low base with sales in Australia? The sp might go lower still but there is also no reason why the sp can't more than double from here in the very short term. Let's not forget it was over $2 last year and that was more than 12 months from any likely sales in the US.
- Forums
- ASX - By Stock
- LTP
- Ann: Commercial Update and Regulatory Progress
LTP
ltr pharma limited
Add to My Watchlist
3.45%
!
30.0¢

Ann: Commercial Update and Regulatory Progress, page-225
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $33.58M |
Open | High | Low | Value | Volume |
29.0¢ | 30.0¢ | 28.5¢ | $105.7K | 362.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 407 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 0.290 |
1 | 24000 | 0.285 |
2 | 230000 | 0.280 |
7 | 175962 | 0.275 |
10 | 192157 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 407 | 1 |
0.305 | 9760 | 1 |
0.310 | 31582 | 3 |
0.315 | 9460 | 1 |
0.320 | 36858 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online